Under the pathological conditions of AD, the amyloid precursor protein (APP) is first cleaved by the beta site APP cleaving enzyme 1 (BACE1) and subsequently primed by γ-secretase, releasing Aβ and stimulating the amyloidogenic pathway [36]. The gene discussed is BACE1; the disease is Alzheimer disease.